from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3106/fprA

LFCtreatmentdescriptionclass of inhibitor

-1.086

Amikacinug/mL Amikacintranslation

-0.294

Cap5-10ug/mL Capreomycintranslation

0.722

Rox10-50 ug/mL Roxithromycintranslation

0.823

SM2-5 ug/mL Streptomycintranslation

-1.356

Tet5-10 ug/mL Tetracyclinetranslation

0.065

Rif0.2-5ug/mL Rifampicintranscription

-0.532

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.318

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.009

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.105

CPZ10-50 ug/mL Chlorpromazinerespiration

0.000

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.167

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.000

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.443

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.373

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.090

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.726

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.276

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.535

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.090

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-2.440

Nigericin50 uM Nigericinrespiration

0.112

TRC10-150 ug/mL Triclosanrespiration

0.613

TRZ10-25 ug/mL Thioridazinerespiration

0.067

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.479

menadione6-10 ug/mL Menadionerespiration

-1.071

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.420

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.290

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.013

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.825

NRP_1Non-replicating persistence stage 1dosRassociated

0.144

Amp0.2mg/mL AmpicillincellWall

0.580

Cephalexin20-100 ug/mL CephalexincellWall

-0.238

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.982

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.376

EMB10-20 ug/mL EthambutolcellWall

0.676

Eta12-40 ug/mL EthionamidecellWall

0.937

INH0.2-0.4 ug/mL IsoniazidcellWall

0.038

TLM0.1-0.2 mg/mL ThiolactomycincellWall

1.153

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.222

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.484

BZA0.12 mg/mL BenzamidearomaticAmides

-0.030

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.591

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

1.090

H2O24 mM hydrogen peroxideDNAdamaging

-0.273

Levo10 ug/mL LevofloxacinDNAdamaging

0.525

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.504

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.338

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.639

UVUV-irradiationDNAdamaging

-0.389

ARP41-4 ug/mL Antitubercular compound ARP4?

0.505

Antimycin12.5-50 ug/mL Antimycin A?

-1.964

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.179

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.686

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.272

PA8240.2-2 ug/mL PA-824?

-0.461

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.150

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-3.557

Verapamil50 uM Verapamil?

-2.431

mercaptoethanol2 mM 2-Mercaptoethanol?

0.326

methoxatin10-20 ug/mL Methoxatin?